Revance Therapeutics, Inc. (RVNC)

Last Three Months

21-Jun-21 -- 20-Sep-21

Time Period:
  • Three Months
  •  | 
  • Year

($3.53M) Net Amount
Buy:0--
Sell:($3.53M)$26.34 - $30.15

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Sentiment Breakdown by Insider
0
(3)
1
(2)
0
(1)
28
0
0
+1
0
+2
0
+3

Two Year Chart

21-Sep-19 -- 20-Sep-21

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Last TransactionLast Three Months
SEC FilingTransactionInsiderSentimentCompanyHoldings ChangeBuy AmountSell AmountBuy Price RangeSell Price Range
02-Jul-21 7:53 PM
View: 
30-Jun-21
Acquisition (other)
$10.74K
Insider Trading Sentiment for Schilke Tobin at Revance Therapeutics, Inc. (RVNC):Revance Therapeutics, Inc. - RVNC1%
68.76K to 69.21K
0
0
---- Show TxnsShow Insider Trades
02-Jul-21 7:52 PM
View: 
30-Jun-21
Acquisition (other)
$21.25K
Foley Mark J
CEO & President
Director
Insider Trading Sentiment for Foley Mark J at Revance Therapeutics, Inc. (RVNC):Revance Therapeutics, Inc. - RVNC0%
881.19K to 882.07K
0
0
---- Show TxnsShow Insider Trades
02-Jul-21 7:56 PM
View: 
30-Jun-21
Acquisition (other)
$21.25K
Sjuts Dustin S
Chief Commercial Officer
Insider Trading Sentiment for Sjuts Dustin S at Revance Therapeutics, Inc. (RVNC):Revance Therapeutics, Inc. - RVNC1%
65.1K to 65.98K
0
0
---- Show TxnsShow Insider Trades
17-Aug-21 6:20 PM
View: 
16-Aug-21
Market Sale (Planned)
($246.66K)
Rankin Aubrey
President, Innovation & Tech
Director
Insider Trading Sentiment for Rankin Aubrey at Revance Therapeutics, Inc. (RVNC):Revance Therapeutics, Inc. - RVNC(19%)
665.4K to 541.38K
0
($3.53M)
(18%)
--$26.34 - $30.15 Show TxnsShow Insider Trades